Search Results - "REINDERS, Janny G"
-
1
Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials
Published in Journal of clinical oncology (10-02-2014)“…To analyze recurrence patterns in patients with cancer of the esophagus or gastroesophageal junction treated with either preoperative chemoradiotherapy (CRT)…”
Get full text
Journal Article -
2
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
Published in Journal of clinical oncology (20-06-2021)“…Preoperative chemoradiotherapy according to the chemoradiotherapy for esophageal cancer followed by surgery study (CROSS) has become a standard of care for…”
Get full text
Journal Article -
3
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Published in The lancet oncology (01-09-2015)“…Summary Background Initial results of the ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS) comparing neoadjuvant chemoradiotherapy…”
Get full text
Journal Article -
4
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial
Published in Journal of clinical oncology (20-01-2018)“…Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patients with esophageal or junctional cancer who received neoadjuvant…”
Get full text
Journal Article -
5
Lymph Node Retrieval During Esophagectomy With and Without Neoadjuvant Chemoradiotherapy: Prognostic and Therapeutic Impact on Survival
Published in Annals of surgery (01-11-2014)“…We aimed to examine the association between total number of resected nodes and survival in patients after esophagectomy with and without nCRT. Most studies…”
Get full text
Journal Article -
6
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial
Published in The Lancet (British edition) (23-10-2004)“…Both single-dose brachytherapy and self-expanding metal stent placement are commonly used for palliation of oesophageal obstruction due to inoperable cancer,…”
Get full text
Journal Article -
7
Brachytherapy versus cystectomy in solitary bladder cancer: A case control, multicentre, East-Netherlands study
Published in Radiotherapy and oncology (01-11-2009)“…Abstract Purpose Comparing the outcome of surgery and brachytherapy-based radiotherapy in patients with solitary T1G3/T2 bladder tumour in, a retrospective…”
Get full text
Journal Article -
8
Saving bladders with brachytherapy: implantation technique and results
Published in International journal of radiation oncology, biology, physics (01-07-2002)“…To analyze and report the treatment results of brachytherapy for solitary bladder cancer in the Arnhem Radiotherapy Institute. Between January 1983 and October…”
Get more information
Journal Article -
9
Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy Increases Histopathological Response Without Affecting Survival in Patients With Esophageal or Junctional Cancer
Published in Annals of surgery (01-11-2014)“…To determine the relation between time to surgery (TTS) after neoadjuvant chemoradiotherapy (nCRT) and pathologically complete response (pCR), surgical…”
Get full text
Journal Article -
10
O200 10-YEAR FOLLOW-UP OF A RANDOMISED CONTROLLED TRIAL COMPARING NEOADJUVANT CHEMORADIOTHERAPY PLUS SURGERY VERSUS SURGERY ALONE FOR OESOPHAGEAL OR JUNCTIONAL CANCER (CROSS)
Published in Diseases of the esophagus (23-11-2019)“…Abstract Aim To report the long term results of the CROSS trial with a minimum follow-up of 10 years. Background Neoadjuvant chemoradiotherapy according to the…”
Get full text
Journal Article -
11
Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up
Published in Radiotherapy and oncology (01-04-1999)“…In patients with Hodgkin's disease treated by radiotherapy with a moderate total dose and a low (mean) fraction dose to the heart, the risk of ischemic heart…”
Get full text
Journal Article -
12
-
13